Vico Therapeutics

About Vico Therapeutics

Vico Therapeutics is committed to advancing RNA modulating therapies for patients with severe, genetic neurological disorders. Vico is initially targeting spinocerebellar ataxia types 3 and 1 and Huntington’s disease. Our VICOMER platform designs antisense oligonucleotides for various genetic defects by modulating or editing RNA. For more information, visit www.vicotx.com

Address

• Headquarters

  J.H. Oortweg 212333CH LeidenZuid-Holland, Netherlands

Team by function

Based on 40 public job profiles as of 4 September 2026.

• Research / R&D19
• Operations5
• Other / Unclassifiable5
• Finance / Accounting4
• HR / People / Recruiting2
• Manufacturing / Production2
• Administrative / Office1
• Executive / C-Suite1
• Legal / Compliance1